The R&D team of WestVac Biopharma originates from the National Key Laboratory of Biotherapy at West China Hospital, Sichuan University, supported by robust technological platforms. The company has secured over 40 patent authorizations (including PCT patents), enabling rapid translation of innovative vaccines, gene and cell therapies, and other novel drugs.
